RYR1 Chromosome 19

Ryanodine receptor 1
1315 variants 24 Drug Response 1291 Health Risk

Upload your DNA to see your personal genotypes for variants in RYR1.

What This Gene Does
This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Gene Info
Gene Group
"Ryanodine receptors|Protein phosphatase 1 regulatory subunits"
Locus Type
gene with protein product
Location
19q13.2
Ensembl
ENSG00000196218
Associated Conditions (74)
Central core myopathy
RYR1-related disorder
King Denborough syndrome
desflurane response - Toxicity
halothane response - Toxicity
enflurane response - Toxicity
isoflurane response - Toxicity
methoxyflurane response - Toxicity
sevoflurane response - Toxicity
succinylcholine response - Toxicity
RYR1-related myopathy
Malignant hyperthermia
susceptibility to
1
Congenital multicore myopathy with external ophthalmoplegia
Malignant hyperthermia of anesthesia
Congenital myopathy with fiber type disproportion
Inborn genetic diseases
Congenital myopathy
Myopathy
+54 more conditions
Key Variants
RS118192124
Likely pathogenic; drug response
Central core myopathy, RYR1-related disorder, King Denborough syndrome
Drug Response
RS121918596
Likely pathogenic; drug response
Malignant hyperthermia, susceptibility to, 1
Drug Response
RS193922748
Likely pathogenic; drug response
RYR1-related disorder, sevoflurane response - Toxicity, Malignant hyperthermia
Drug Response
RS193922762
Likely pathogenic; drug response
Malignant hyperthermia, susceptibility to, 1
Drug Response
RS193922770
Likely pathogenic; drug response
RYR1-related disorder, desflurane response - Toxicity, halothane response - Toxicity
Drug Response
RS193922818
Likely pathogenic; drug response
RYR1-related disorder, Malignant hyperthermia, susceptibility to
Drug Response
RS193922832
Likely pathogenic; drug response
RYR1-related disorder, sevoflurane response - Toxicity, desflurane response - Toxicity
Drug Response
RS193922876
Likely pathogenic; drug response
desflurane response - Toxicity, enflurane response - Toxicity, succinylcholine response - Toxicity
Drug Response
RS193922878
Likely pathogenic; drug response
desflurane response - Toxicity, halothane response - Toxicity, isoflurane response - Toxicity
Drug Response
RS28933397
Likely pathogenic; drug response
Malignant hyperthermia, susceptibility to, 1
Drug Response
RS118192122
Pathogenic; drug response
Central core myopathy, Malignant hyperthermia, susceptibility to
Drug Response
RS118192161
Pathogenic; drug response
Malignant hyperthermia, susceptibility to, 1
Drug Response
All Variants (1315)
RSID Category Clinical Significance Conditions
RS377664510 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia
RS398123469 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Inborn genetic diseases, Limb-girdle muscular dystrophy
RS398123470 Health Risk Conflicting classifications of pathogenicity
RS398123471 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Centronuclear myopathy, Central core myopathy
RS398123473 Health Risk Conflicting classifications of pathogenicity Central core myopathy, Malignant hyperthermia, susceptibility to
RS45496799 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, RYR1-related disorder
RS531823936 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS532101469 Health Risk Conflicting classifications of pathogenicity Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia, susceptibility to
RS536148030 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Congenital myopathy with fiber type disproportion, Malignant hyperthermia
RS536304635 Health Risk Conflicting classifications of pathogenicity Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia, susceptibility to
RS536596969 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Central core myopathy, Malignant hyperthermia
RS537344365 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS538250432 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS538500669 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Central core myopathy, Malignant hyperthermia
RS539194350 Health Risk Conflicting classifications of pathogenicity Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia, susceptibility to
RS539829239 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Inborn genetic diseases, RYR1-related disorder
RS540088883 Health Risk Conflicting classifications of pathogenicity Central core myopathy, Malignant hyperthermia, susceptibility to
RS540264243 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS543026464 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS543458339 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS544339193 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, King Denborough syndrome, Congenital multicore myopathy with external ophthalmoplegia
RS546280470 Health Risk Conflicting classifications of pathogenicity Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia, susceptibility to
RS547048377 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS548280516 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS548515798 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS551228795 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS551509462 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS552470353 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS552725260 Health Risk Conflicting classifications of pathogenicity Central core myopathy, Malignant hyperthermia, susceptibility to
RS555470100 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS559157737 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, RYR1-related disorder
RS559581937 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Central core myopathy, Congenital multicore myopathy with external ophthalmoplegia
RS561546643 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS56338790 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS565173276 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS565825739 Health Risk Conflicting classifications of pathogenicity Central core myopathy, Congenital myopathy with fiber type disproportion, Congenital multicore myopathy with external ophthalmoplegia
RS566495420 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS567084532 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS569565316 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS570469685 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS571569206 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS571850239 Health Risk Conflicting classifications of pathogenicity Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia, susceptibility to
RS572516017 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Inborn genetic diseases, RYR1-related disorder
RS573431795 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS574357386 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS575446156 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Central core myopathy, Inborn genetic diseases
RS575528695 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS576990255 Health Risk Conflicting classifications of pathogenicity Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia, susceptibility to
RS577314143 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, RYR1-related disorder
RS587784373 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, RYR1-related myopathy, RYR1-related disorder
« Prev 1 ... 7 8 9 10 11 12 13 ... 27 Next »
Sign Up to Analyze Your DNA Log In